Virginia 2022 Regular Session

Virginia Senate Bill SB414

Introduced
1/11/22  
Refer
1/11/22  
Report Pass
2/3/22  
Engrossed
2/7/22  
Refer
2/22/22  
Report Pass
2/24/22  
Engrossed
3/1/22  
Engrossed
3/3/22  
Enrolled
3/8/22  
Chaptered
4/11/22  

Caption

Nurse practitioners; patient care team physician supervision capacity increased.

Impact

The bill's passage potentially alters how healthcare is delivered in Virginia, particularly in primary care settings. By enabling nurse practitioners to prescribe a wider range of medications, it facilitates a more efficient healthcare process, allowing these professionals to manage patient care more independently. The amendment to ยง54.1-2957.01 of the Code of Virginia sets a clear framework for practice agreements, ensuring that the authority given to nurse practitioners is underpinned by regulatory oversight to maintain a standard of care for patients.

Summary

SB414 focuses on expanding the prescriptive authority of licensed nurse practitioners in Virginia, allowing them to prescribe Schedule II through Schedule VI controlled substances and devices. This bill aims to increase the capacity of nurse practitioners in providing patient care by enhancing their autonomy and reducing dependency on physicians for prescribing medications. Through this legislation, the aim is to improve access to healthcare services, especially in underserved areas where medical professionals may be in short supply.

Sentiment

The overall sentiment surrounding SB414 appears to be positive among healthcare stakeholders, particularly those advocating for expanded roles of nurse practitioners. Supporters argue that the bill addresses the critical need for more accessible health services, enhances continuity of care, and empowers nurse practitioners, who are increasingly taking on greater responsibilities in patient care. Nonetheless, there are concerns from some quarters about maintaining the quality and safety of patient care under this expanded prescriptive authority.

Contention

One of the notable points of contention lies in the potential risks associated with increased autonomy for nurse practitioners. Critics worry about the implications of nurse practitioners prescribing medications without sufficient oversight from physicians. These concerns revolve around patient safety, the adequacy of training for nurse practitioners, and whether they can effectively handle complex medical situations that require a deeper level of expertise. Additionally, the bill outlines specific limitations on the number of nurse practitioners a physician can oversee, aiming to ensure that supervision remains practical and effective, but also raising questions about its impact on collaborative healthcare models.

Companion Bills

No companion bills found.

Similar Bills

VA HB2183

Nurse practitioners; practice authority upon licensure.

VA HB285

Clinical nurse specialist; practice agreements.

VA HB896

Nurse practitioner; patient care team provider.

NJ A3342

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.

VA SB1105

Nurse practitioners and licensed certified midwives; licensed by the Board of Nursing only.

AZ SB1125

Psychologists; prescribing authority

CT SB00431

An Act Concerning Changes To Prescription Drug Abuse Statutes.

VA HB978

Advanced practice registered nurses and licensed certified midwives; joint licensing.